DB

Dipal Bijal Brahmabhatt

Active Director Director DIN 08039974
DIN 08039974 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Dipal Bijal Brahmabhatt

Data last updated:

Dipal Bijal Brahmabhatt is a Director at Will Impex Pharmachem Private Limited (since 2018). The company operates in Pharma. Will Impex Pharmachem Private Limited reported revenue of ₹8.24 Cr (FY 2025).

DIN 08039974
Primary Designation Director
Industry Pharma
First Appointment 03 May 2018
Oldest Company Age 8 yrs
Largest company Will Impex Pharmachem Private Limited · ₹8.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 May 20182018₹8.24 Cr (FY 2025)Active

Board colleagues of Dipal Bijal Brahmabhatt

Directorship timeline

Open interactive timeline →
Will Impex Pharmachem Private Limited
Premium access

Shareholding and investment profile for Dipal Bijal Brahmabhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipal Bijal Brahmabhatt

Dipal Bijal Brahmabhatt currently holds 1 directorship: Will Impex Pharmachem Private Limited (Director, since 03 May 2018, revenue ₹8.24 Cr (FY 2025)).

Dipal Bijal Brahmabhatt was first appointed on 03 May 2018 as Director at Will Impex Pharmachem Private Limited.

The current boards of Dipal Bijal Brahmabhatt's companies include Bijalbhai Girishchandra Brahmbhatt (Will Impex Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available